Can an occipital (posterior‑circulation) stroke be caused by a patent foramen ovale (PFO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Occipital Stroke Be From PFO?

Yes, occipital (posterior circulation) strokes can absolutely be caused by patent foramen ovale (PFO) through paradoxical embolism, and this anatomical location is actually more frequently associated with PFO-related strokes than other territories.

Evidence Supporting PFO as a Cause of Occipital Stroke

The strongest evidence comes from a population-based study showing that patients with medium to large PFOs (≥2 mm) more frequently had occipital and infratentorial strokes compared to those with small or no PFOs (57% versus 27%; P=0.02) 1. This finding directly demonstrates that posterior circulation strokes, including occipital infarcts, are significantly associated with PFO presence and size.

Additional case evidence confirms this mechanism—a documented case of a 33-year-old woman with migraine and PFO who developed an acute right occipital ischemic stroke, which was successfully treated with PFO closure 2. The Lausanne Study similarly found that posterior cerebral artery territory infarcts were associated with stroke recurrence in PFO patients 3.

Mechanism: Why Occipital Territory?

The mechanism involves paradoxical embolism—venous thrombi or right atrial thrombi bypass the pulmonary circulation through the right-to-left shunt created by the PFO, entering the arterial circulation directly 4. The posterior circulation (vertebrobasilar system) appears particularly vulnerable to this embolic mechanism, though the exact reason for this predilection is not fully established.

Clinical Assessment Algorithm

When evaluating an occipital stroke for PFO causation, follow this structured approach:

1. Confirm Cryptogenic Status

First, rule out other causes through:

  • Prolonged cardiac rhythm monitoring (exclude atrial fibrillation)
  • Transesophageal echocardiography (exclude left atrial thrombus, aortic atheroma)
  • Carotid and vertebrobasilar imaging (exclude large vessel disease)
  • Exclude other cardioembolic sources 5, 4

2. Assess PFO Characteristics

Use transesophageal echocardiography (higher sensitivity than transthoracic) to evaluate 4:

  • Shunt size: Large shunts (>20 microbubbles) increase stroke likelihood
  • Atrial septal aneurysm (ASA): High-risk anatomical feature that significantly increases embolic risk
  • Tunnel length and anatomy

3. Calculate Risk of Paradoxical Embolism (RoPE) Score

This validated tool stratifies likelihood that PFO caused the stroke 5:

  • Factors favoring PFO causation: Younger age, absence of hypertension/diabetes/prior stroke, cortical (or occipital) infarct on imaging
  • Score 0-3: 0-4% probability PFO-related
  • Score 9-10: 83-91% probability PFO-related

4. Look for Venous Thrombosis Source

Search for deep vein thrombosis or other venous sources—if present, this strongly supports paradoxical embolism mechanism 6, 3.

Treatment Recommendations Based on Current Guidelines

For patients under 60 years with cryptogenic occipital stroke and PFO 4:

Strong Recommendation:

PFO closure plus antiplatelet therapy is superior to antiplatelet therapy alone when anticoagulation is contraindicated or declined 4.

Weak Recommendation:

For patients open to all options, PFO closure plus antiplatelet therapy is preferred over anticoagulation alone 4.

Key Considerations:

  • High-risk anatomical features (large shunt, ASA) show greater benefit from closure 5
  • The 2021 AHA/ASA guidelines emphasize that younger patients without other vascular risk factors are more likely to have PFO-related strokes 5
  • Applicability decreases with age >60 and presence of traditional cerebrovascular risk factors 4

Critical Pitfalls to Avoid

  1. Don't assume all occipital strokes with PFO are PFO-related: PFO is present in 25% of the general population—it may be incidental. Use the RoPE score and anatomical features to assess causality 5.

  2. Don't overlook competing causes: Even with PFO present, 16% of patients have alternative stroke causes (atrial fibrillation, severe mitral valve prolapse, akinetic left ventricular segments) 3.

  3. Don't close PFOs in older patients without careful consideration: Benefits diminish and risks increase with age >60 and presence of traditional risk factors 4.

  4. Don't forget to assess for venous thrombosis: If DVT is proven, this strongly supports paradoxical embolism and mandates anticoagulation regardless of closure decision 6.

Bottom Line

Occipital strokes are significantly more common with medium-to-large PFOs and represent a classic presentation of paradoxical embolism. In appropriately selected young patients (<60 years) with cryptogenic occipital stroke, high RoPE scores, and high-risk PFO features (large shunt, ASA), closure provides substantial benefit in preventing recurrence 5, 4, 1.

References

6
Research

Patent foramen ovale and cryptogenic stroke: a matter of age?

Seminars in thrombosis and hemostasis, 2009

Related Questions

Is travel to altitudes of 7,900–10,000 feet contraindicated for a patient with an unrepaired patent foramen ovale (PFO) who has a history of cerebrovascular accident (stroke)?
Is a patent foramen ovale (PFO) in a patient with systemic lupus erythematosus (SLE) who develops dengue infection rare, what is its approximate prevalence, and is there a pathophysiologic relationship?
In a patient with an occlusive thrombus in the proximal‑to‑mid right gastrocnemius muscle and a potential right‑to‑left cardiac shunt (e.g., patent foramen ovale), is it appropriate to label the resulting stroke as cryptogenic?
Can a patent foramen ovale (PFO) cause headaches in a patient without atrial fibrillation, prior thromboembolic events, a mechanical valve, or a closure device?
For a patient with a small patent foramen ovale, what precautions and recommendations should be followed when traveling to higher elevations?
What is the classification of gallbladder carcinoma?
What are the recommended starting dose, titration schedule, and urinary monitoring/management guidelines for intrathecal hydromorphone in a patient with cancer pain?
What are the management options for a patient with a chronic tracheostomy who develops tracheomalacia?
What medical conditions can mimic anxiety disorders?
Can selective serotonin reuptake inhibitors (SSRIs) increase the risk of new-onset suicidal ideation in a patient with no prior history of suicidal thoughts?
Could an occlusive thrombus in the proximal-to-mid right gastrocnemius muscle cause a stroke, or are the mechanisms separate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.